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Abstract Temporin A is a small, basic, highly hydrophobic,
antibacterial peptide found in the skin of the European red frog,
Rana temporaria. It was synthesized twice by the FastMoc solid
phase method using amino acids protected at the NK-position
with either 9-fluorenylmethoxycarbonyl or 2-(4-nitrophenylsul-
fonyl)ethoxycarbonyl. The syntheses of temporin A demonstrates
the difference between 2-(4-nitrophenylsulfonyl)ethoxycarbonyl
and 9-fluorenylmethoxycarbonyl amino acids. The purified
peptide showed also antibacterial activity against clinically
important Gram-positive bacteria. It was found to have a
moderately good activity against both methicillin resistant and
sensitive strains of Staphylococcus aureus, but a weaker activity
against vancomycin resistant strains of Enterococcus faecium.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
The temporins (temporins A^G, H, K, L) are a group of 10
small (13 amino acids), basic (net charge at pH 7 = +1^+2),
hydrophobic peptide amides that have been isolated from the
skin of the European red frog, Rana temporaria [1]. They are
among the smallest antibacterial peptides that have been iso-
lated from animal sources. They are active against both
Gram-positive and -negative bacteria and are found to be
non-toxic to human red blood cells.
Temporin A (FLPLIGRVLSGIL-NH2) has been synthe-
sized previously by the solid phase 9-£uorenylmethoxycarbon-
yl (Fmoc) methodology ([1], Donatella Barra, personal com-
munication). Compared with two similar antibacterial
peptides isolated from insect sources, melittin (a 26 amino
acid peptide amide [2]) and cecropin A (a 37 amino acid pep-
tide amide [3]), temporin A was 10-fold less potent than me-
littin against Staphylococcus aureus Cowan I (S.a.CI), a com-
mon laboratory test strain of S. aureus (lethal concentration
(LC) = 2.3 versus 0.2 WM), but greater than 100-fold more
potent than cecropin A against the same bacterium
(LC = 2.3 versus s 200 WM).
The purposes of this investigation were (1) to synthesize
temporin A using amino acids protected at the NK-group
with Nsc, a relatively new protecting group for the solid phase
peptide synthesis [4], with a standard automated synthesis
program, (2) to compare the synthesis with the one done using
Fmoc-protected amino acids, (3) to con¢rm the identity of the
products of each synthesis by standard analytical techniques
and (4) to assay the peptide for activity against clinically
important strains of Gram-positive bacteria.
2. Materials and methods
2.1. Peptide synthesis, puri¢cation and characterization
Temporin A was synthesized twice on an Applied Biosystems model
433A Peptide Synthesizer with the manufacturer’s pre-de¢ned Fast-
Moc chemistry options which use a 10-fold molar excess of amino
acids over resin loading, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethy-
luronium tetra£uoroborate/N-hydroxybenzotriazole/N,N-diisopropyl-
ethylamine activation, deprotection with 20% piperidine and N-meth-
ylpyrrolidone as the solvent. Syntheses were done in a 0.05 mmol scale
with 9 min coupling times and under feedback controlled repeats of
2 min deprotection reactions. Each cycle of amino acid addition in-
cluded the capping reaction in which unreacted primary amines were
acetylated with acetic anhydride. The syntheses di¡ered in two ways:
(1) the type of NK-protection was either Fmoc or 2-(4-nitrophenylsul-
fonyl)ethoxycarbonyl (Nsc) and (2) the length of the time for depro-
tection of the NK-group was modi¢ed from 2 min/reaction with Fmoc
to 5 min with Nsc in the ¢rst reaction and 3 min in each repeat. The
deprotection times programmed for each cycle of the Nsc synthesis
were increased because the Nsc group is known to require more time
for removal than the Fmoc group [4]. Fmoc amino acids were pur-
chased either from Novabiochem (San Diego, California, USA) or
Senn Chemicals AG, (Dielsdorf, Switzerland). Nsc amino acids were
a generous gift from Dr Hack-Joo Kim (Research Institute, Hyundai
Pharm., Seoul, South Korea). The side chain protecting groups were
the same for both the Nsc and Fmoc amino acids, t-butyl ether for
serine and 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulphonyl for
arginine. The solid phase used was Rink amide resin (Novabiochem,
substitution = 0.56 mmol/g). After synthesis was completed, the pep-
tide was de-protected and cleaved from the resin by treatment with
tri£uoroacetic acid (TFA)/thioanisole/ethanedithiol/water (90/5/2.5/
2.5) at room temperature for 2 h. The peptide was then precipitated
from the cleavage solution by adding ice-cold diethyl ether into the
mixture, followed by centrifugation. The precipitate was washed twice
with 40 ml of ether, dissolved in water, frozen and lyophilized.
The peptide synthesized with Nsc amino acids was then analyzed by
reversed phase high performance liquid chromatography (RP-HPLC)
on a 0.46U25 cm, 5 Wm particle size, Vydac 218TP54 C18 column,
eluting with a 50 min gradient of 0^100% acetonitrile (CH3CN)-0.1%
TFA/H2O-0.1% TFA with a £ow rate of 1 ml/min and monitoring the
eluate at 210 nm. Three major peaks were detected. In order to obtain
enough material for bacteriological assays, a 12.5 mg amount of crude
peptide was subjected to preparative RP-HPLC (Fig. 1A), using con-
ditions similar to those mentioned above, except that the column was
a Vydac 1U25 cm, 10 Wm particle size, 218TP101522 C18 and the
£ow rate was 5 ml/min. Three main fractions were collected, CH3CN
was evaporated by a stream of N2 and the aqueous peptide solutions
were frozen and lyophilized. The three resulting puri¢ed fraction pow-
ders were each analyzed by electrospray ionization mass spectrometry
(ESI-MS) as described previously [5].
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For the peptide synthesized with Fmoc amino acids, the HPLC
procedures were similar. Analytical RP-HPLC gave a tailing major
peak which had the same retention time as temporin A in the Nsc
synthesis. Puri¢cation of 13 mg of crude peptide was done with a 10
min gradient of 0^21% CH3CN/H2O-0.1% TFA, followed by a 40 min
gradient of 21^70% CH3CN/H2O-0.1% TFA and 10 min of isocratic
elution at 70% CH3CN-H2O-0.1% TFA. Fractions corresponding to
the main peak (Fig. 1B) were pooled, lyophilized and subjected to
ESI-MS.
Amino acid analysis was carried out using a Pharmacia-LKB 4151
Alpha Plus analyzer after hydrolysis for 24 h at 110‡C in evacuated
tubes with 6 M hydrochloric acid containing 0.5% (w/v) phenol.
2.2. Bacterial strains and media
Three bacterial strains of S. aureus and two strains of Enterococcus
faecium were used in the studies. Methicillin sensitive S. aureus strain
K52 and methicillin resistant strain K35 as well as the vancomycin
resistant E. faecium strains 18578 and 18172, which carried the vanA
and vanB genes, respectively, were clinical isolates originating from
the Department of Bacteriology and Immunology, HUCH Diagnos-
tics, Helsinki University Central Hospital. The third staphylococcal
strain was the laboratory strain, Newman. For the experiments, bac-
terial strains were maintained on chocolate agar plates.
2.3. Determination of minimal inhibitory concentration (MIC) and
bacterial killing
MIC values were determined by using a microdilution technique.
Bacterial suspensions of each strain, corresponding to a McFarland
value of 1.0, were diluted 1:1000 in Mueller-Hinton broth containing
Ca2 and an aliquot (25 Wl) was mixed with an aliquot (25 Wl) of 2-
fold dilutions of temporin A in de-ionized H2O. The MIC was de¢ned
as the lowest concentration of temporin A allowing no visible growth
after 20 h of incubation at 37‡C.
To determine the bacterial killing, 10 Wl of a suitable dilution made
from microdilution wells was spread on Mueller-Hinton agar plates
and colony forming units (CFUs) were counted after an overnight
incubation at 37‡C. Dilutions giving 20^500 bacterial colonies per
plate were used for colony counting.
3. Results
3.1. Peptide synthesis, puri¢cation and characterization
During automated Fmoc synthesis, the NK-deprotection
steps of each cycle of amino acid addition are feed-back moni-
tored by measuring the amount of a conductive piperidine-
carbamate salt that is formed. The FastMoc protocol speci¢es
that a deprotection step is repeated until there is less than 4%
di¡erence in conductivities between successive couplings. The
conductivity of the Nsc synthesis was recorded as in the Fmoc
synthesis. A comparison of the Fmoc and Nsc synthesis
showed that for the Nsc synthesis each deprotection reaction
was repeated three times (14 min in total) except for serine
which was repeated twice (11 min in total), whereas for the
Fmoc synthesis each deprotection reaction was repeated only
twice (6 min in total), indicating, as expected, a slower remov-
al of Nsc.
Fig. 1 shows preparative RP-HPLC chromatograms of the
crude product obtained from cleavage of the peptides from
resin. As indicated by the ESI-MS (¢gure insets) for the pu-
ri¢ed peptide fractions, temporin A was found in the Nsc
synthesis preparation in the central major peak (Fig. 1A)
and in Fmoc synthesis preparation in the major peak (Fig.
1B). Each preparation had a molecular ion corresponding to
the expected mass to charge (m/z) ratio of the single charged
species, 1397, and also a predominant ion corresponding to
the double charged species, m/z 699. Analytical RP-HPLC of
the puri¢ed temporin As from both syntheses gave chromato-
grams with single peaks, indicating pure peptide products
Fig. 1. Chromatograms from preparative RP-HPLCs of the crude
peptide products from Nsc (A) and Fmoc (B) syntheses of temporin
A shown as absorbance U at 210 nm post injection. In (A), the
peak of puri¢ed temporin A is the central major peak and in (B), it
is the major peak. ESI-MS results of all temporin A containing
fractions are shown as insets, with the m/z ratio as the horizontal
axis and abundance as the vertical axis.
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(data not shown). Separation of temporin A into two major
fractions was observed in Nsc but not in Fmoc synthesis. This
may re£ect a tendency of temporin A to aggregate either with
itself or with the observed synthetic side-product(s).
Amino acid analysis con¢rmed that the puri¢ed temporin A
had the correct amino acid composition and the result was
also used to establish the concentrations of peptide solutions
in subsequent bacteriological assays.
3.2. Bacteriological assays
Temporin A inhibited the growth of both S. aureus and E.
faecium. MICs for S. aureus strain Newman and both S. au-
reus strains K35 and K52 were 6.8 WM and 13.7 WM, respec-
tively (Table 1). The corresponding values for E. faecium
strains 18578 and 18172 were 27.3 WM and 54.6 WM, respec-
tively (Table 1).
Temporin A was also bacteriocidal to S. aureus and E.
faecium. CFUs of S. aureus strains were reduced more than
90% at a temporin A concentration of 6.8 WM and further 5^6
orders of magnitude at temporin A concentrations of 13.7 WM
(Fig. 2). The peptide was bacteriocidal to E. faecium only at
the highest concentrations used (54.6 WM), where the bacterial
numbers were reduced ¢ve orders of magnitude for E. faecium
strain 18578 and less than four orders of magnitude for the
strain 18172 (Fig. 2).
4. Discussion
There is one report in the literature about temporin pep-
tides [1]. It contains the ¢rst description of the naturally oc-
curring temporins and compares the biological properties of
the naturally isolated forms, A, B, D and H, to the synthetic
versions of the peptides. It was shown that temporins A and B
have antimicrobial activities and that these activities were the
same for both naturally occurring and synthetic versions. The
goals of this investigation were to attempt the FastMoc syn-
thesis of temporin A using amino acids protected at the NK-
group with Nsc and to compare the synthetic product with
that obtained using Fmoc-protected amino acids. The addi-
tional purpose was to test the antimicrobial e¡ects of the
puri¢ed peptide against clinically important methicillin sensi-
tive and resistant S. aureus strains, as well as against vanco-
mycin resistant E. faecium strains.
The Nsc group has been proposed as an appropriate tem-
porary protecting group for the K-amine in amino acids dur-
ing solid phase synthesis [6]. It has an increased stability in
neutral and weakly basic dimethylformamide solutions as
compared to Fmoc. It apparently has the same mechanism
of cleavage by organic bases as does the Fmoc group,
although at rates of cleavage that are 3^8-fold slower than
for Fmoc. Comparisons of interferon K2 (130-137), acyl car-
rier protein (65-74) and ACTH(1-24), that were synthesized in
the solid phase by using both Nsc and Fmoc amino acids and
identical side chain protecting groups, revealed that the crude
products of Nsc and Fmoc syntheses yielded essentially the
same HPLC pro¢les [6]. The results of the syntheses of tem-
porin A using Nsc or Fmoc amino acids were in line with
previous syntheses. Temporin A is a hydrophobic peptide
compared to the three other peptides mentioned above and
very hydrophobic peptides often present synthetic di⁄culties
like deletion and termination peptides [7]. In the Nsc synthe-
sis, the relative amount of deletion peptides (50%) eluting
prior to temporin A was estimated to be 6% more than in
Fmoc synthesis (44%) (Fig. 1). The observed synthesis di¡er-
ence is most probably due to incomplete NK-deprotections in
case of Nsc, a result which for long or di⁄cult peptides pro-
poses low yields in FastMoc protocols using Nsc amino acids.
Lengthening of the reaction time up to 3^8-fold appears nec-
essary, but extends deprotection cycles (20^50 min in a 0.1
mmol scale). Therefore, use of a higher concentration of pi-
peridine or complementation of 20% piperidine with the
stronger base 1,8-diazabicyclo(5,4,0)undec-7-ene-1,1,3,3-tetra-
methyl guanidine are feasible changes for Nsc synthesis [6].
In regard to the bacteriological experiments with temporin
A derived from the Nsc synthesis, the peptide had a moder-
ately good activity against the three S. aureus strains but a
weak activity against the E. faecium strains. CFUs of staph-
ylococcal strains were reduced more than 90% at a temporin
A concentration of 6.8 WM. Whereas a similar e¡ect against
E. faecium strains was seen at a temporin A concentration
higher than 27.3 WM. The values are somewhat higher than
the lethal concentration of 2.3 WM reported for the S.a.CI
laboratory strain [1]. It is di⁄cult to compare the values be-
cause di¡erent methods were used to determine the bacterio-
cidal concentration (also Cowan I was not included in the
present study). Interestingly, the bacteriocidal e¡ect of tempo-
rin A appeared similar against both the methicillin resistant
and sensitive strains, which suggests that methicillin sensitivity
Fig. 2. The bacteriocidal e¡ect of temporin A against S. aureus
strain Newman (open circle) and strains K35 (closed circle) and
K52 (closed square) and against E. faecium strains 18578 (open tri-
angle) and 18172 (closed triangle).
Table 1
Capability of temporin A to inhibit the growth of Gram-positive
bacteria
Bacterium Strain MICa
Wg/ml WM
S. aureus : Newman 9.5 6.8
K35 19.5 13.7
K52 19.5 13.7
E. faecium 18578 38.1 27.3
18172 76.3 54.6
aMinimal inhibitory concentration.
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is not related to the mechanism of action of this peptide.
Methicillin is a L-lactam that inhibits the bacterial peptido-
glycan synthesis, whereas the mechanism of action of tempo-
rin A is thought to involve the formation of ion channels or
pores in the bacterial plasma membrane. There appeared to be
a slight di¡erence in the potency of the peptide against the
two vancomycin resistant enterococci. In a separate experi-
ment (data not shown), a vancomycin sensitive E. faecium
strain was found to be as sensitive to temporin A as the
vancomycin resistant strains, suggesting that vancomycin sen-
sitivity, like methicillin sensitivity, is also unrelated to the
temporin A sensitivity. Di¡erences in susceptibilities to van-
comycin may be related to di¡erences between bacterial
strains or di¡erences in their cell walls. In summary, these
antibacterial results are promising and it should be possible
to improve the antibiotic activities of temporin A by synthetic
manipulations of its primary structure, as has been accom-
plished for many similar peptides [8].
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